Cargando…
Risperidone and Levothyroxine for Managing “Myxedema Madness”
Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526983/ https://www.ncbi.nlm.nih.gov/pubmed/33014650 http://dx.doi.org/10.7759/cureus.10152 |
_version_ | 1783588960744767488 |
---|---|
author | Patel, Rikinkumar S Heer, Arpit S Lesko, Aquila Kim, Sung W Ishaq, Muhammad |
author_facet | Patel, Rikinkumar S Heer, Arpit S Lesko, Aquila Kim, Sung W Ishaq, Muhammad |
author_sort | Patel, Rikinkumar S |
collection | PubMed |
description | Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while admitting laboratory works are processed. It has been found that antipsychotic use is associated with lower free thyroxine levels, so untreated hypothyroid patients may experience worsening of symptoms with antipsychotic use. It is recommended that hypothyroid patients with psychosis be treated for the underlying hypothyroidism with thyroid hormone replacement. In this article, we are presenting a case of a hypothyroid patient presenting to a psychiatric facility for worsening psychosis and persecutory delusions, and medication non-compliance to levothyroxine. We also discuss the management of psychosis in a patient with worsening hypothyroidism with a combination regimen: levothyroxine and risperidone. |
format | Online Article Text |
id | pubmed-7526983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-75269832020-10-01 Risperidone and Levothyroxine for Managing “Myxedema Madness” Patel, Rikinkumar S Heer, Arpit S Lesko, Aquila Kim, Sung W Ishaq, Muhammad Cureus Endocrinology/Diabetes/Metabolism Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while admitting laboratory works are processed. It has been found that antipsychotic use is associated with lower free thyroxine levels, so untreated hypothyroid patients may experience worsening of symptoms with antipsychotic use. It is recommended that hypothyroid patients with psychosis be treated for the underlying hypothyroidism with thyroid hormone replacement. In this article, we are presenting a case of a hypothyroid patient presenting to a psychiatric facility for worsening psychosis and persecutory delusions, and medication non-compliance to levothyroxine. We also discuss the management of psychosis in a patient with worsening hypothyroidism with a combination regimen: levothyroxine and risperidone. Cureus 2020-08-31 /pmc/articles/PMC7526983/ /pubmed/33014650 http://dx.doi.org/10.7759/cureus.10152 Text en Copyright © 2020, Patel et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Patel, Rikinkumar S Heer, Arpit S Lesko, Aquila Kim, Sung W Ishaq, Muhammad Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title | Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title_full | Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title_fullStr | Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title_full_unstemmed | Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title_short | Risperidone and Levothyroxine for Managing “Myxedema Madness” |
title_sort | risperidone and levothyroxine for managing “myxedema madness” |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526983/ https://www.ncbi.nlm.nih.gov/pubmed/33014650 http://dx.doi.org/10.7759/cureus.10152 |
work_keys_str_mv | AT patelrikinkumars risperidoneandlevothyroxineformanagingmyxedemamadness AT heerarpits risperidoneandlevothyroxineformanagingmyxedemamadness AT leskoaquila risperidoneandlevothyroxineformanagingmyxedemamadness AT kimsungw risperidoneandlevothyroxineformanagingmyxedemamadness AT ishaqmuhammad risperidoneandlevothyroxineformanagingmyxedemamadness |